Critical appraisal of ophthalmic ketorolac in treatment of pain and inflammation following cataract surgery
Rahul Reddy, Stephen Jae KimDepartment of Ophthalmology, Vanderbilt University, Nashville, TN, USABackground: The purpose of this review was to provide a critical appraisal of the literature supporting the efficacy of ophthalmic ketorolac (Acuvail®) in the treatment of pain and inflammat...
Guardado en:
Autores principales: | Reddy RK, Kim SJ |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b8c7d4d96542419f96368a3dd2c953fd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Safety and efficacy of loteprednol etabonate ophthalmic ointment 0.5% for the treatment of inflammation and pain following cataract surgery
por: Timothy L Comstock, et al.
Publicado: (2011) -
Critical appraisal of loteprednol ointment, gel, and suspension in the treatment of postoperative inflammation and pain following ocular and corneal transplant surgery
por: Pirouzian A, et al.
Publicado: (2014) -
The clinical utility of new combination phenylephrine/ketorolac injection in cataract surgery
por: Lawuyi LE, et al.
Publicado: (2015) -
Intracameral ketorolac concentration at the beginning and end of cataract surgery following preoperative topical ketorolac administration
por: Katsev DA, et al.
Publicado: (2017) -
Difluprednate ophthalmic emulsion 0.05% (Durezol®) administered two times daily for managing ocular inflammation and pain following cataract surgery
por: Stephen Smith, et al.
Publicado: (2010)